Evidence map›Paper›PMID 42548084›Full record

ReviewJournal of immunology research2026

Natural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives.

Dilimulati Yalikun, Lulu Si, Hanlin Fu, Ruixia Guo

Abstract readReview
In one paragraph

Review in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dilimulati YalikunDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City 450052, Henan Province, China, zzu.edu.cn.ORCID https://orcid.org/0009-0000-1391-2461
Lulu SiDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City 450052, Henan Province, China, zzu.edu.cn.ORCID https://orcid.org/0000-0002-1722-6271
Hanlin FuDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City 450052, Henan Province, China, zzu.edu.cn.ORCID https://orcid.org/0000-0002-2184-9770
Ruixia GuoDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City 450052, Henan Province, China, zzu.edu.cn.ORCID https://orcid.org/0000-0002-8847-2488

Funding

National Natural Science Foundation of China 82273229National Natural Science Foundation of China 82403060Provincial-Ministrial Co-constructed Key Program of Henan Province SBGJ202302074Young Talent Support Program of Natural Science Foundation of Henan Province 242300420385
6 · The paper itself

Abstract

Uterine adenomyosis (AM), a common gynecological disorder, is characterized by the invasion of endometrial glands and stroma into the myometrium, resulting in chronic pelvic inflammation and severe pain. This condition not only adversely affects patients' quality of life but also correlates with diminished fertility. Recent findings underscore the critical role of natural killer (NK) cells in the pathophysiology of AM. As a vital component of innate immunity, NK cells are responsible for identifying and eliminating abnormal cells, and functional alterations of NK cells may contribute to the progression of this disease. Although existing research has suggested preliminary associations between NK-cell dysfunction and AM, the exact mechanistic pathways and their clinical implications are still not fully elucidated. This review comprehensively explores the involvement of NK cells in AM, emphasizing their functional adaptability within the immune microenvironment, interactions with cytokine networks, and potential for therapeutic targeting. Furthermore, we critically assess the translational hurdles and propose a strategic framework for implementing NK cell-based immunomodulatory approaches in clinical practice.

Indexed as

AdenomyosisKiller Cells, NaturalAnimalsCellular MicroenvironmentCytokinesFemaleHumansImmunity, InnateImmunomodulationImmunotherapyUterusCytokinesadenomyosisfertilityimmune microenvironmentimmunotherapymechanismnatural killer cells

Identifiers

PMID42548084
PMCPMC13434032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.